Allegations of cracked aluminum wheels in Chevrolet Corvettes have given rise to a class action lawsuit, claiming that certain models suffer from rims that crack and bend, leading to tire leaks and blowouts.​

The complaint, filed in the U.S. District Court for the Northern District of California, specifically targets 2015 to present Chevy Corvette Z06 and 2017 to present Corvette Grand Sport cars. The lawsuit asserts that these vehicles are equipped with rims made from a less durable cast material rather than forged, potentially compromising their structural integrity. 

California resident Richard Barrington, one of the plaintiffs, purchased a new 2018 Chevrolet Corvette Grand Sport, only to discover a right rear tire leak within one or two months. Technicians confirmed that the rear wheel was cracked in three places, necessitating replacement. Subsequently, Barrington faced a similar issue with the driver-side rear wheel, allegedly denied warranty coverage by General Motors (GM). Despite driving the Corvette normally, Barrington claims to have spent approximately $3,000 replacing six cracked wheels. 

The lawsuit contends that GM knowingly used cheaper cast aluminum and reduced material to save weight, making the rims insufficiently robust for regular driving conditions. This alleged issue has persisted since the cars were first sold, with GM purportedly aware of the problem but insisting that the rims are not defective. Corvette owners seeking warranty-covered wheel repairs are reportedly denied, leading them to shoulder the financial burden of replacing allegedly cracked wheels. 

Citing a Car and Driver magazine report titled “Wheel Woes,” the lawsuit alleges evidence of the widespread nature of the cracked wheel problem. The report includes a review of a 2017 Chevrolet Corvette Grand Sport that experienced three bent wheels, incurring a $1,119 repair bill.

Michael Yarnoff, Partner with the Kehoe Law Firm, expressed satisfaction with the filing of the complaint, stating, “We believe the claims are meritorious, and we are very pleased with the progress of the case.” 

Kehoe Law Firm remains committed to representing the interests of the affected consumers and seeks a fair resolution for those impacted by the alleged defects. 

For more information about Kehoe Law Firm and its involvement in this matter, please contact Michael Yarnoff at [email protected] or call (215) 792-6676.

The United States District Court for the Central District of California has granted final approval to the securities litigation class action filed against NantHealth, Inc. and certain of its executives and directors. The suit alleged violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.​

Initiated on June 26, 2017, the case saw the Southern Pennsylvania Transit Authority appointed as lead plaintiff with the Kehoe Law Firm appointed co-lead counsel. The lawsuit claimed that NantHealth and its officers and directors misled investors by overstating the market demand for NantHealth’s genetic sequencing services. The lawsuit also claimed that NantHealth made false statements or omitted material information from its financial statements and in other public statements. NantHealth and its officers and directors deny they did anything wrong.​

The Court granted class certification on July 30, 2019, and on January 31, 2020, preliminarily approved the settlement. The approved settlement establishes a $16,500,000.00 common fund for investors, less attorney fees and expenses.​

The Court found the proposed pro rata distribution fair and adequate, especially considering the absence of objections from class members. The requested attorneys’ fees of 25% were deemed presumptively reasonable given the complexity of the case. Additionally, the court granted SEPTA a $5,000.00 incentive award for its substantial efforts in the case.​

John Kehoe, lead counsel from the Kehoe Law Firm, remarked, “This settlement is a testament to the diligent efforts of all involved parties. The approved terms reflect a fair and just resolution for the class members. We are pleased with the Court’s decision and believe it underlines the strength of our case.”​

For more information, visit www.NantHealthSecuritiesLitigation.com, call 1-844-975-1779, or write to the Settlement Administrator, NantHealth, Inc. Securities Litigation, c/o JND Legal Administration, PO Box 91125, Seattle, WA 98111.​

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.

Kehoe Law Firm is pleased to announce that a partial settlement has been reached with two defendants in the Mexican Government Bonds antitrust litigation. The settlements total $20,700,000 and were reached with Barclays PLC (and related entities) and JPMorgan Chase & Co. (and related entities), on behalf of our client, Southeastern Pennsylvania Transportation Authority Pension Plan (“SEPTA”), and additional plaintiffs.​

The settlement addresses allegations that the settling defendants, and others, conspired to fix the prices for Mexican Government Bonds issued by the Mexican government through the Bank of Mexico (“Banxico”). As alleged in the complaint, each defendant transacted in price fixed MGBs at artificial prices with uninformed market participants like Plaintiffs and the Class. Defendants allegedly did so through several interrelated means of manipulation.​

SEPTA and plaintiffs’ lead counsel engaged in separate negotiations with Barclays and JPMorgan to reach negotiated resolutions of the claims against them. The Settlements allow SEPTA, Barclays, and JPMorgan to avoid the risks and costs of lengthy litigation and the uncertainty of pre-trial proceedings, a trial, and appeals, and, if approved, would permit eligible settlement class members, who file timely and valid claim forms, to receive compensation rather than risk ultimately receiving nothing.​

SEPTA and plaintiffs’ lead counsel believe the $20,700,000 partial settlements are in the best interest of all settlement class members. Notably, the settlement does not include many other defendants that have chosen to not participate at this time. These defendants include entities related to Bank of America, Citibank, Deutsche Bank, HSBC, and others.​

For more information about the case and the partial settlement, see a website maintained by the Mexican Government Bonds at: https://www.mgbantitrustsettlement.com/ 

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.

Kehoe Law Firm, court appointed lead counsel in the securities litigation captioned Deora v. NantHealth, Inc., No. 2:17-cv-01825-TJH-MRW, pending in the United States District Court for the Central District of California, announces the successful resolution of the class action. The case concerns the pricing of NantHealth stock, and the proposed settlement, valued at $16.5 million, is set to address claims by investors who purchased NantHealth common stock between June 1, 2016, and May 1, 2017. 

Partner John A. Kehoe expressed satisfaction with the outcome, stating, “We are pleased to have represented Southeastern Pennsylvania Transportation Authority and to have achieved this extraordinary settlement in light of the risks of continued litigation.” 

Investors who acquired NantHealth stock between June 1, 2016, and May 1, 2017, are eligible for benefits, provided they bought the shares individually and not through a mutual fund. Certain individuals, including NantHealth officers, directors, and their families, are not considered Class Members.

The lawsuit alleged that NantHealth and officers and directors misled investors about the demand for its services. The settlement, while not admitting wrongdoing, aims to provide benefits to investors. The disagreement between the parties on potential trial outcomes led to the decision to settle.

NantHealth will establish a $16.5 million settlement fund to address claims by all Class Members. Payments will be determined based on the number of valid claim forms, the quantity of NantHealth stock purchased, and the timing of transactions. The settlement also includes attorneys’ fees, cost reimbursements, and a compensatory award for the Class Representative. 

Class Members can qualify for payment by submitting a claim form or doing so online by May 22, 2020. The detailed notice package, available through the website or by calling 1-844-975-1779, contains all necessary information. 

Class Members have the option to exclude themselves from the settlement by May 22, 2020, to retain the ability to pursue individual legal actions. Alternatively, they can object to the settlement by the same date. The Court will hold a hearing on June 15, 2020, to decide on the settlement’s approval.

For more information, visit www.NantHealthSecuritiesLitigation.com, call 1-844-975-1779, or write to the Settlement Administrator, NantHealth, Inc. Securities Litigation, c/o JND Legal Administration, PO Box 91125, Seattle, WA 98111.​

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.